to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Fatal central venous catheter-related infection in haemophilia.
Application of current knowledge to the management of bleeding events during immune tolerance induction.
Rituximab for treatment of inhibitors in haemophilia A. A Phase II study.
Extended half-life factor VIII for immune tolerance induction in haemophilia.
Consensus recommendations for use of central venous access devices in haemophilia.
Developing a multidisciplinary Young Women's Blood Disorders Program: a single-centre approach with guidance for other centres.
Catheter-related deep venous thrombosis in children with hemophilia.
Tissue plasminogen activator to prevent central venous access device infections: a systematic review of central venous access catheter thrombosis, infection and thromboprophylaxis.
Arthroscopic synovectomy in children and adolescents with hemophilia.
Implantable central venous access device procedures in haemophilia patients without an inhibitor: systematic review of the literature and institutional experience.
Deep venous thrombosis screening in patients with inherited bleeding disorders and central venous catheters.
Desmopressin (DDAVP) in the management of patients with congenital bleeding disorders.
PERSEPT 3: A phase 3 clinical trial to evaluate the haemostatic efficacy of eptacog beta (recombinant human FVIIa) in perioperative care in subjects with haemophilia A or B with inhibitors.
The safety of activated eptacog beta in the management of bleeding episodes and perioperative haemostasis in adult and paediatric haemophilia patients with inhibitors.
Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (<12 years) with haemophilia A or B with inhibitors.